UPTRAVI is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Actelion Pharmaceuticals Us, Inc.. The primary component is Selexipag.
Product ID | 66215-612_32a13445-38fd-4dcd-b2e1-e84b7c11d4b6 |
NDC | 66215-612 |
Product Type | Human Prescription Drug |
Proprietary Name | UPTRAVI |
Generic Name | Selexipag |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2015-12-21 |
Marketing Category | NDA / NDA |
Application Number | NDA207947 |
Labeler Name | Actelion Pharmaceuticals US, Inc. |
Substance Name | SELEXIPAG |
Active Ingredient Strength | 1200 ug/1 |
Pharm Classes | Prostacyclin Receptor Agonist [EPC],Prostacyclin Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2015-12-21 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA207947 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2015-12-21 |
Ingredient | Strength |
---|---|
SELEXIPAG | 1200 ug/1 |
SPL SET ID: | a7a23b87-f892-4e2c-8e2e-ebf841220f90 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
66215-602 | UPTRAVI | Selexipag |
66215-604 | UPTRAVI | Selexipag |
66215-606 | UPTRAVI | Selexipag |
66215-608 | UPTRAVI | Selexipag |
66215-610 | UPTRAVI | Selexipag |
66215-612 | UPTRAVI | UPTRAVI |
66215-614 | UPTRAVI | UPTRAVI |
66215-616 | UPTRAVI | UPTRAVI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
UPTRAVI 86829111 5074971 Live/Registered |
Actelion Pharmaceuticals Ltd 2015-11-23 |
UPTRAVI 85348761 4087965 Live/Registered |
Actelion Pharmaceuticals Ltd 2011-06-17 |